Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases
Status: Enrolling
Updated:  12/31/1969
University of California, San Francisco, San Francisco General Hospital
mi
from
San Francisco, CA
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases
Status: Enrolling
Updated: 12/31/1969
University of California, San Francisco, San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging
Pilot Study for: Eye vs. Spy - A Prospective, Randomized Study Evaluating Patient Outcomes With the Use of SPY Imaging During Amputations or Debridements
Status: Enrolling
Updated:  12/31/1969
Georgetown University Medical Center; Center for Wound Healing
mi
from
Washington,
Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging
Pilot Study for: Eye vs. Spy - A Prospective, Randomized Study Evaluating Patient Outcomes With the Use of SPY Imaging During Amputations or Debridements
Status: Enrolling
Updated: 12/31/1969
Georgetown University Medical Center; Center for Wound Healing
mi
from
Washington,
Click here to add this to my saved trials
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated:  12/31/1969
Kernersville YMCA.
mi
from
Kernersville, NC
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated: 12/31/1969
Kernersville YMCA.
mi
from
Kernersville, NC
Click here to add this to my saved trials
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated:  12/31/1969
William G. White YMCA
mi
from
Winston-Salem, NC
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated: 12/31/1969
William G. White YMCA
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated:  12/31/1969
Fulton YMCA
mi
from
Winston-Salem, NC
Cooperative Lifestyle Programs (CLIP-II)
Cooperative Lifestyle Programs (CLIP-II)
Status: Enrolling
Updated: 12/31/1969
Fulton YMCA
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
A Double Blind, Randomized, Placebo Controlled Study to Determine the Physiological Effectiveness of Januvia for Reducing Inflammation and Increasing EPC Number in HIV Infected Men and Women With Insulin Resistance and Central Adiposity.
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
A Double Blind, Randomized, Placebo Controlled Study to Determine the Physiological Effectiveness of Januvia for Reducing Inflammation and Increasing EPC Number in HIV Infected Men and Women With Insulin Resistance and Central Adiposity.
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
University of California at Davis Health System
mi
from
Sacramento, CA
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
University of California at Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Denver, CO
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
National Heart, Lung, and Blood Institute
mi
from
Bethesda, MD
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
National Heart, Lung, and Blood Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Buffalo Medical Group
mi
from
Buffalo, NY
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Buffalo Medical Group
mi
from
Buffalo, NY
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Menter Dermatology Research Institute
mi
from
Dallas, TX
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Menter Dermatology Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
An Intravenous, Open-label, Single-dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of rhLCAT in Subjects With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Cardiovascular and Pulmonary Branch (CPB) of NIH
mi
from
Bethesda, MD
Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
An Intravenous, Open-label, Single-dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of rhLCAT in Subjects With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Cardiovascular and Pulmonary Branch (CPB) of NIH
mi
from
Bethesda, MD
Click here to add this to my saved trials
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function
Status: Enrolling
Updated:  12/31/1969
Suburban Hospital
mi
from
Bethesda, MD
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function
Status: Enrolling
Updated: 12/31/1969
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Arizona Sun Family Medicine
mi
from
Gilbert, AZ
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Arizona Sun Family Medicine
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Fiel Family Medicine
mi
from
Tempe, AZ
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Fiel Family Medicine
mi
from
Tempe, AZ
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Town Lake Internal Medicine
mi
from
Woodstock, GA
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Town Lake Internal Medicine
mi
from
Woodstock, GA
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Maringouin Medical Center
mi
from
Maringouin, LA
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Maringouin Medical Center
mi
from
Maringouin, LA
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
The Bonin Clinic
mi
from
Zachary, LA
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
The Bonin Clinic
mi
from
Zachary, LA
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Triangle Primary Care
mi
from
Wake Forest, NC
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Triangle Primary Care
mi
from
Wake Forest, NC
Click here to add this to my saved trials
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated:  12/31/1969
Comprehensive Physicians Associates
mi
from
Youngstown, OH
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test: Results From a Prospective Registry Study.
Status: Enrolling
Updated: 12/31/1969
Comprehensive Physicians Associates
mi
from
Youngstown, OH
Click here to add this to my saved trials
Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease
Representational Telehealth Nursing Intervention for Veterans With CHD
Status: Enrolling
Updated:  12/31/1969
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease
Representational Telehealth Nursing Intervention for Veterans With CHD
Status: Enrolling
Updated: 12/31/1969
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Click here to add this to my saved trials
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina, Pediatric Cardiology - Site 6019
mi
from
Charleston, SC
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina, Pediatric Cardiology - Site 6019
mi
from
Charleston, SC
Click here to add this to my saved trials
Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging
Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging; Independent Scientist: ARFI and RWI Ultrasound for Improved Atherosclerosis Imaging
Status: Enrolling
Updated:  12/31/1969
The University of North Carolina at Chapel Hill Hospitals
mi
from
Chapel Hill, NC
Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging
Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging; Independent Scientist: ARFI and RWI Ultrasound for Improved Atherosclerosis Imaging
Status: Enrolling
Updated: 12/31/1969
The University of North Carolina at Chapel Hill Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Hoag Hospital
mi
from
Newport Beach, CA
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Hoag Hospital
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Denver, CO
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Grady Health System
mi
from
Atlanta, GA
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Kaleida Health
mi
from
Buffalo, NY
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Kaleida Health
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Hospital
mi
from
Stony Brook, NY
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
St. Joseph Hospital- Healtheast
mi
from
Saint Paul, MN
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
St. Joseph Hospital- Healtheast
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Univ. of Florida College Medicine
mi
from
Jacksonville, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Univ. of Florida College Medicine
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Unit of Miami
mi
from
Miami, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Unit of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Progressive Medical Research
mi
from
Port Orange, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Black Hills Cardiovascular Research
mi
from
Rapid City, SD
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Black Hills Cardiovascular Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
West Houston Area Clinical Trial Consultants
mi
from
Houston, TX
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
West Houston Area Clinical Trial Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
Cardiology Center of Houston
mi
from
Katy, TX
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Cardiology Center of Houston
mi
from
Katy, TX
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
University Hospital of Wales
mi
from
Heath Park,
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
University Hospital of Wales
mi
from
Heath Park,
Click here to add this to my saved trials
Chocolate Balloon Angioplasty Registry
Chocolate Balloon Angioplasty Registry
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Heart and Vascular
mi
from
Elk Grove Village, IL
Chocolate Balloon Angioplasty Registry
Chocolate Balloon Angioplasty Registry
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Heart and Vascular
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials